NLC-propolis demonstrates anti-breast cancer activity by increasing antioxidant levels, suppressing angiogenesis, inflammatory and mTOR pathways, and inducing the apoptotic pathway. This leads to an increase in the expression of miRNA-223, contributing to the suppression of breast cancer. The gene discussed is MTOR; the disease is breast carcinoma.